Iron absorption from salt double fortified with iodine in iron-deficient Indian women.
- Registration Number
- CTRI/2020/11/028936
- Lead Sponsor
- Bill and Melinda Gates Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Written informed consent
Female, 18 to 40 years old
SF < 25 µg/L
Normal body Mass Index (18.5 â?? 25 kg/m2)
Bodyweight <= 65 kg
Pregnancy (assessed by self-declaration)
Lactating up to 6 weeks before study initiation
Anemia (Hb < 12.0 g/dL)
Elevated CRP ( >5.0 mg/L)
Consumption of mineral and vitamin supplements within 2 weeks before 1st meal administration
Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months
Earlier participation in a study using Fe stable isotopes or participation in any clinical study within the last 30 days
A participant who cannot be expected to comply with the study protocol (e.g. not available on certain study appointments)
Continuous/long-term use of medication during the whole study (except for contraceptives)
Any metabolic, gastrointestinal kidney or chronic diseases such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases
Smokers ( > 1 cigarette per week)
Difficulties with blood sampling
Male gender
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare encapsulated ferrous fumarate (FeFum) with co-encapsulated FePP and with solubilizing agents.Timepoint: 2:Baseline and Endline.
- Secondary Outcome Measures
Name Time Method To compare in iron-deficient Indian women (Serum Ferritin lesser than 25ug/L) fractional iron absorption (FIA) from double fortified with iodine and different iron compounds. <br/ ><br>To determine the iron status and inflammatory markers. <br/ ><br>To evaluate the sensory properties of the different double fortified salts in local foods using triangle and acceptability tests. <br/ ><br>To determine the stability of color and iodine concentration in double fortified salt during a 6-month storage trial. <br/ ><br>Timepoint: 2:Baseline and Endline.